Journal of the American Academy of Dermatology
-
J. Am. Acad. Dermatol. · May 2013
Dermatologists perform the majority of cutaneous reconstructions in the Medicare population: numbers and trends from 2004 to 2009.
Dermatologists are experts in skin cancer treatment. Their experience with cutaneous reconstruction may be underrecognized. ⋯ DS perform the highest volumes of repairs in the Medicare population. DS play a primary role in routine and advanced cutaneous reconstructive surgery, especially of aesthetically important regions.
-
J. Am. Acad. Dermatol. · May 2013
Frontal fibrosing alopecia: a retrospective review of 19 patients seen at Duke University.
Frontal fibrosing alopecia (FFA) is a type of scarring hair loss primarily observed in postmenopausal women and characterized by fronto-tempero-parietal hairline recession, perifollicular erythema, and loss of eyebrows. The incidence is unknown, but the number of women presenting with this condition has significantly increased in recent years. No effective therapy has been established. ⋯ FFA is an increasingly common form of scarring hair loss, but the origin remains unknown. Without clear understanding of the pathogenesis and evolution of this condition, it is not surprising that treatments to date have been minimally or not effective. At our institution, dutasteride was most effective in halting disease progression, although no therapy was associated with significant hair regrowth.
-
J. Am. Acad. Dermatol. · May 2013
Randomized Controlled TrialA double-blind, randomized, placebo-controlled trial of adalimumab in the treatment of cutaneous sarcoidosis.
Many medications, including tumor necrosis factor antagonists, have been anecdotally reported to be effective in treating cutaneous sarcoidosis, but controlled study is lacking. ⋯ Adalimumab, at the dose and duration of treatment used in this study, is likely to be an effective and relatively safe suppressive treatment for cutaneous sarcoidosis.